Auspherix

About:

Auspherix is an Australian early stage anti-infectives company developing novel antibiotics to treat resistant bacterial diseases.

Website: https://synchronicityhempoil.com

Twitter/X: auspherix

Top Investors: Brandon Capital, Medical Research Commercialisation Fund (MRCF), Imperial Innovations

Description:

Auspherix, an Australian early stage anti-infectives company. Auspherix will seek further investment or industry partnerships to move the novel antibiotics into pre-clinical and clinical development, potentially for broad spectrum use.

Total Funding Amount:

$11M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Stevenage, Herefordshire, United Kingdom

Founded Date:

2013-01-01

Contact Email:

info(AT)auspherix.com

Founders:

Ian Charles

Number of Employees:

11-50

Last Funding Date:

2015-06-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai